These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 25559660)

  • 1. [Patient knowledge about their treatment according to the therapeutic class: misplaced antiplatelet].
    Franchitti J; Desmaizières M; Reuter PG; Galinski M; Adnet F; Lapostolle F
    Presse Med; 2015 Mar; 44(3):354-6. PubMed ID: 25559660
    [No Abstract]   [Full Text] [Related]  

  • 2. Coronary stents and antiplatelet therapy: patients' and health professionals' understanding of the implications.
    Bauer WO; Ng L; Jones C; O'Riordan J
    J Cardiothorac Vasc Anesth; 2010 Apr; 24(2):383-4. PubMed ID: 19447649
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of preinjury anticoagulants and prescription antiplatelet agents on outcomes in older patients with traumatic brain injury.
    Peck KA; Calvo RY; Schechter MS; Sise CB; Kahl JE; Shackford MC; Shackford SR; Sise MJ; Blaskiewicz DJ
    J Trauma Acute Care Surg; 2014 Feb; 76(2):431-6. PubMed ID: 24458049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving patient knowledge of discharge medications in an oncology setting.
    Berry DL; Cunningham T; Eisenberg S; Wickline M; Hammer M; Berg C
    Clin J Oncol Nurs; 2014 Feb; 18(1):35-7. PubMed ID: 24476724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effect of antiplatelet therapy in retinal vein occlusion evaluated by the particle-counting method using light scattering.
    Yamamoto T; Kamei M; Yokoi N; Yasuhara T; Tei M; Kinoshita S
    Am J Ophthalmol; 2004 Nov; 138(5):809-17. PubMed ID: 15531317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial experiences with Multiplate® for rapid assessment of antiplatelet agent activity in neurosurgical emergencies.
    Beynon C; Scherer M; Jakobs M; Jung C; Sakowitz OW; Unterberg AW
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2003-8. PubMed ID: 23830497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using clopidogrel bisulfate: a new antiplatelet drug.
    Pfister SM
    Nurse Pract; 1999 Sep; 24(9):100-1, 105-8, 110. PubMed ID: 10507077
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic patient education in health centers in the Lorraine region of France - an EPATEL study].
    Legrand K; Gendarme S; Coyard H; Xia K; Empereur F; Collin JF
    Sante Publique; 2012; 24(2):93-104. PubMed ID: 22789115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Randomised comparative study of early versus delayed surgery in hip-fracture patients on concomitant treatment with antiplatelet drugs. Determination of platelet aggregation, perioperative bleeding and a review of annual mortality].
    Mas-Atance J; Marzo-Alonso C; Matute-Crespo M; Trujillano-Cabello JJ; Català-Tello N; de Miguel-Artal M; Forcada-Calvet P; Fernández-Martínez JJ
    Rev Esp Cir Ortop Traumatol; 2013; 57(4):240-53. PubMed ID: 23885649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual antiplatelet therapy in patients with stable coronary artery disease in modern practice: prevalence, correlates, and impact on prognosis (from the Suivi d'une cohorte de patients COROnariens stables en region NORd-Pas-de-Calais study).
    Lemesle G; Lamblin N; Meurice T; Tricot O; Lallemant R; Nugue O; Delomez M; Equine O; Tondeux S; Bauters C
    Am Heart J; 2014 Oct; 168(4):479-86. PubMed ID: 25262257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two antiplatelet therapy strategies in patients undergoing transcatheter aortic valve implantation.
    Durand E; Blanchard D; Chassaing S; Gilard M; Laskar M; Borz B; Lafont A; Barbey C; Godin M; Tron C; Zegdi R; Chatel D; Le Page O; Litzler PY; Bessou JP; Danchin N; Cribier A; Eltchaninoff H
    Am J Cardiol; 2014 Jan; 113(2):355-60. PubMed ID: 24169016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacogenetics and antiplatelet drugs].
    Fontana P; Reny JL
    Rev Med Interne; 2005 Sep; 26(9):725-32. PubMed ID: 16154027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting stents: patient understanding of the risks of premature cessation of antiplatelet drugs.
    Trentman TL; Rosenfeld DM; Danielson DR; Hagstrom SG
    J Cardiothorac Vasc Anesth; 2008 Dec; 22(6):806-10. PubMed ID: 18834797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry.
    Bauriedel G; Skowasch D; Schneider M; Andrié R; Jabs A; Lüderitz B
    Am Heart J; 2003 Feb; 145(2):343-8. PubMed ID: 12595854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study.
    Velik-Salchner C; Maier S; Innerhofer P; Kolbitsch C; Streif W; Mittermayr M; Praxmarer M; Fries D
    Anesth Analg; 2009 Jun; 108(6):1747-54. PubMed ID: 19448196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of clopidogrel besylate and clopidogrel hydrogensulfate on platelet aggregation in patients with coronary artery disease: a retrospective study.
    Borsiczky B; Sarszegi Z; Konyi A; Szabados S; Gaszner B
    Thromb Res; 2012 Jun; 129(6):700-3. PubMed ID: 21924759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiplatelet agents and their therapeutic use].
    Lecompte T
    Rev Prat; 1999 Oct; 49(15):1627-33. PubMed ID: 10581992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in the prescription of cardiovascular prevention drugs in France between 1995 and 2003: factors influencing the gap between evidence base medicine and clinical practice].
    Philippe F; Cambou JP; Danchin N; Thomas D
    Ann Cardiol Angeiol (Paris); 2005 Dec; 54 Suppl 1():S30-6. PubMed ID: 16411649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis at 6 months for coronary and cerebrovascular patients: impact of antiplatelet agents and statins: results from the Prevenir III study.
    Ferrières J; Cambou JP; Cantet C; Guize L
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):55-61. PubMed ID: 16552472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.